https://www.google.com/search?sca_esv=4808aced13c4ef62&rlz=1C1VDKB_en-GBAU1110AU1110&sxsrf=AHTn8zqa5HXNG6_lBMdS8fjostcvPfNbWg:1740653551528&q=willy+wonka+golden+ticket&udm=7&fbs=ABzOT_CWdhQLP1FcmU5B0fn3xuWpA-dk4wpBWOGsoR7DG5zJBsxayPSIAqObp_AgjkUGqekYoUzDaOcDDjQfK4KpR2OIjj43mhrQBsMJgHY2LSx-SUj4wz68xSZ8iYTfqgrdxb3MJvHOMODdIcpti-xYMckL_DuO7Mno3LlWlsnznPPjfINcnPSb3s0mY1_Udv3xmGYGwDe_3zR2JNQT7OndwaUM5c3nJw&sa=X&ved=2ahUKEwjZpvbk1-OLAxWeS2cHHY91IgUQtKgLegQIERAB&biw=1312&bih=802&dpr=1.5#fpstate=ive&vld=cid:17a28c01,vid:1Fxq_n8e1qA,st:0
- Forums
- ASX - By Stock
- CYP
- Why Cynata's GvHD Treatment Might Not Need a Phase Two Trial for FDA Approval
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.5¢

Why Cynata's GvHD Treatment Might Not Need a Phase Two Trial for FDA Approval, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 16.0¢ | $29.18K | 176.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 66467 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 66467 | 0.160 |
4 | 181490 | 0.155 |
5 | 318045 | 0.150 |
4 | 81775 | 0.145 |
4 | 307863 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 65000 | 1 |
0.185 | 35419 | 2 |
0.190 | 114978 | 3 |
0.195 | 5764 | 1 |
0.200 | 55400 | 2 |
Last trade - 15.59pm 25/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online